Edition:
United Kingdom

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

4.50USD
21 Mar 2019
Change (% chg)

-- (--)
Prev Close
$4.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
93,803
52-wk High
$17.39
52-wk Low
$3.25

Select another date:

Wed, Jan 30 2019

UPDATE 4-Roche, AC Immune drop Alzheimer drug trials after setback

* AC Immune shares plunge 65 percent (Adds AC Immune CEO commment, shares)

Lilly partners with AC Immune for Alzheimer's treatment

U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

UPDATE 1-Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 Eli Lilly & Co and AC Immune SA have agreed to jointly develop a potential treatment for Alzheimer's disease.

Select another date: